Thyroid News

Children born to mothers diagnosed with thyroid disorders before or during pregnancy were significantly more likely to develop thyroid cancer, with risk persisting into adulthood, according to an analysis of registry data.

More than one-third of individuals taking thyroid hormone replacement remained euthyroid after discontinuing their medication, according to study findings published in Thyroid.

The FDA granted orphan drug designation to an investigational therapy to treat hypoparathyroidism, according to an industry press release.

Women with hyperthyroidism had improvements in bone mineral density and bone microarchitecture 1 year after attaining euthyroid status, according to findings published in Thyroid.

A cohort of euthyroid individuals with Hashimoto’s thyroiditis were more likely to eat meat and less likely to adhere to a Mediterranean diet than healthy controls, according to findings published in Thyroid.

Follow-up ultrasound scans conducted in adults treated for low- to intermediate-risk papillary thyroid cancer are more likely to detect nonactionable findings than clinically significant disease, according to study data.

A cohort of pregnant women in Canada who were overtreated for hypothyroidism with levothyroxine were more likely to have a preterm delivery than women with normal thyroid-stimulating hormone, according to a study published in Thyroid.

The FDA granted accelerated approval to pralsetinib for treatment of certain patients with RET-altered thyroid cancer.

Analysis of more than 3,000 COVID-19-positive adults in New York City showed no association between a history of hypothyroidism and risks for COVID-19 hospitalization, mechanical ventilation or death, according to study data.

Patients with chronic HF and hyperthyroidism or hypothyroidism have increased risk for death compared with patients with normal thyroid levels, according to a retrospective analysis published in the American Journal of Cardiology.